Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2349030 | 0.82 | TSHR (0.57) | TSHRTHRBUSP2CYP3A4MAPT | |
| SCHEMBL5076278 | 0.81 | — | — | |
| SCHEMBL17350649 | 0.81 | TSHR (0.55) | TSHRTHRBUSP2CYP3A4MAPT | |
| SCHEMBL15249364 | 0.80 | TSHR (0.64) | TSHRTHRBALDH1A1POLBAPEX1 | |
| Propene SCHEMBL28456176 | 0.79 | TSHR (0.53) | TSHRTHRBUSP2CYP3A4MAPT | |
| SCHEMBL94906 | 0.79 | TSHR (0.68) | TSHRTHRBUSP2CYP3A4MAPT | |
| SCHEMBL631029 | 0.79 | TSHR (0.68) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL2585229 | 0.79 | TSHR (0.68) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL20854815 | 0.79 | TSHR (0.68) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL16863053 | 0.78 | TSHR (0.61) | TSHRTHRBUSP2CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008004735-A1 | MICROPATTERN-FORMING RESIN COMPOSITON AND METHOD FOR FORMING MICROPATTERN USING THE SAME | CHEIL INDUSTRIES INC. (KR) | 2008-01-10 | — | — | WO | claimed |
| CN-118852507-A | Polymer, preparation method thereof, gel polymer electrolyte, battery and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2024-10-29 | — | — | CN | disclosed |
| US-8383314-B2 | Photocurable liquid developer, method for producing the same, developing device and image forming apparatus | RICOH COMPANY, LTD. (JP) | 2013-02-26 | — | — | US | disclosed |
| EP-2348363-B1 | Photocurable liquid developer, method for producing the same, developing device and image forming apparatus | RICOH CO LTD (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20110183254-A1 | PHOTOCURABLE LIQUID DEVELOPER, METHOD FOR PRODUCING THE SAME, DEVELOPING DEVICE AND IMAGE FORMING APPARATUS | RICOH COMPANY, LTD. (JP) | 2011-07-28 | — | — | US | disclosed |
| EP-2348363-A1 | Photocurable liquid developer, method for producing the same, developing device and image forming apparatus | Ricoh Company, Ltd. (JP) | 2011-07-27 | — | — | EP | disclosed |
| WO-2008004735-A1 | MICROPATTERN-FORMING RESIN COMPOSITON AND METHOD FOR FORMING MICROPATTERN USING THE SAME | CHEIL INDUSTRIES INC. (KR) | 2008-01-10 | — | — | WO | disclosed |
| US-6541657-B2 | An unsaturated carboxylate which has both an unsaturated group and a hydroxyl group; making by reacting an acrylic acid with and unsaturated oxirane; use as reactive diluent in radical-curable resin | NIPPON SHOKUBAI CO., LTD (JP) | 2003-04-01 | — | — | US | disclosed |
| US-20010051744-A1 | Unsaturated carboxylate and its production process and use | NIPPON SHOKUBAI CO., LTD. | 2001-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010051744-A1 | Unsaturated carboxylate and its production process and use | OXGR1, OXER1, OGDH | TSHR 2287/4885THRB 2589/4885USP2 3135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.